EVALUATION OF DYSPLASTIC EXPRESSION IN ORAL LEUKOPLAKIA BY CLINICAL, HISTOPATHOLOGY AND IMMUNOHISTOCHEMISTRY BY CYTOKERATIN 19 MARKER (CK 19) – A COMPARATIVE STUDY

Sathyanarayana P, Rajendra Patil

Abstract


Introduction: Oral cancers contribute to over 30 % of all malignancies in India. Leukoplakia being one of the most common precancerous lesions can be detected clinically by in vivo staining procedures there by helping in early identification of this pre cancerous lesions and aid in early treatment initiation. Therefore the present study was conducted to compare the dysplastic expression in oral leukoplakia by toluidine blue staining, histopathology and immunohistochemistry (IHC) using CK 19 marker expression.

Objectives: To compare dysplasia in oral premalignant lesion leukoplakia by clinical, histopathological and IHC using CK 19 marker.

Materials and methods: Prospective comparative study was conducted on 15 patients who were found positive clinically with leukoplakia and there after comparing the dysplasia using toluidine blue staining, histopathology and Immunohistochemistry using CK 19 marker. Statistical analysis was done using SPSS version 16

Results: Of the 15 patients who were clinically suspected to have oral leukoplakia, 12 (80%), 10 (66.7%) and 8 (53.33%) cases were found to be positive on toluidine blue staining, histopathology and immunohistochemistry respectively.

Conclusion: In the present study Toluidine blue was found to be sensitive in identifying precancerous lesions and can be used an adjunct to clinical diagnosis there by helping in early detection of oral cancer. This diagnosis can be confirmed using histopathology and IHC using CK 19 marker in detecting mild to moderate dysplasia at the early stages. 


Keywords


Chronic liver disease, Liver cirrhosis, Non-alcoholic fatty liver disease.

Full Text:

PDF

References


Dangi J, Kinnunen TH, Zavras AI. Challenges in global improvement of oral cancer outcomes: Findings from rural Northern India. Tob Induc Dis. 2012;10:5

Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–80.

World Health Organization Collaborating Center for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978;46:518-39.

Allegra E, Lombardo N, Puzzo L, Garozzo A. The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions. Acta Otorhinolaryngol Ital. 2009;29(4):187–190.

Jemal A, Thimas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:181-2.

Woolgar JA, Scott J, Vaughan ED, Brown JS, West CR, Rogers S. Survival, metastasis and recurrence of oral cancer in relation to pathological features. Ann R Coll Surg Engl 1995;77:325-31

Banoczy J, Sugar L. Longitudinal studies on oral leukoplakia. J Oral Pathol 1972;1:265-9.

Chiesa F, Tradati N, Sala L, Costa L, Podrecca S, Baracchi P, et al. Follow-up of oral leukoplakia after carbon dioxide laser surgery. Arch Otolaryngol Head Neck Surg 1990;116:177-80.

Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant tranformation. Cancer 1984;53:563-8.

Carrard VC, van der Waal I. A clinical diagnosis of oral leukoplakia; A guide for dentists. Med Oral Patol Oral Cir Bucal. 2018;23(1):e59–e64. Published 2018 Jan 1. doi:10.4317/medoral.22292

S. K. Jindal, A. N. Aggarwal, K. Chaudhry, S. K. Chhabra, G. A. D'Souza, D. Gupta, S. K. Katiyar, R. Kumar, B. Shah, V. K. Vijayan, et al. Tobacco smoking in India: prevalence, quit-rates and respiratory morbidity.

Indian J Chest Dis Allied Sci. 2006 Jan-Mar; 48(1): 37–42

V. V. S. Ram Prassad, N. Rao Nirmala, M. S. Kotian. Immunohistochemical evaluation of expression of cytokeratin 19 in different histological grades of leukoplakia and oral squamous cell carcinoma. Indian J Dent Res. 2005 Jan-Mar; 16(1): 6–11.


Refbacks

  • There are currently no refbacks.